Clinical Study
Comparison of Enoxaparin and Warfarin for Secondary Prevention of Cancer-Associated Stroke
Table 4
Multiple logistic regression analysis: independent predictors of D-dimer levels ≥10 μg/mL.
| | Estimated OR | | | Univariable | Multivariable | | | (95% CI†) | (95% CI) | |
| Treatment | | | | Enoxaparin | Reference | Reference | | Warfarin | 6.72 (1.92–23.58) | 12.95 (2.89–57.94) | 0.001 | Systemic metastasis | 6.96 (0.80–60.53) | 18.73 (1.69–207.48) | 0.017 | Adenocarcinoma | 3.58 (0.86–14.87) | 2.41 (0.43–13.44) | 0.314 |
|
|
OR: odds ratio; †CI: confidence interval.
|